title: Severe cold hemagglutinin disease (CHD) successfully treated with rituximab.
authors.forename: Monika
authors.initials: M
authors.lastname: Engelhardt
authors.forename: Andreas
authors.initials: A
authors.lastname: Jakob
authors.forename: Björn
authors.initials: B
authors.lastname: Ruter
authors.forename: Martin
authors.initials: M
authors.lastname: Trepel
authors.forename: Friedrich
authors.initials: F
authors.lastname: Hirsch
authors.forename: Michael
authors.initials: M
authors.lastname: Lübbert
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy* / Q000503:physiopathology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001663:Bilirubin / Q000378:metabolism; D002452:Cell Count; D005260:Female; D006454:Hemoglobins / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D012156:Reticulocytes / Q000187:drug effects / Q000473:pathology; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D006454:Hemoglobins; D000069283:Rituximab; D001663:Bilirubin